Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.

The rat monoclonal antibody CAMPATH-1 recognizes a hitherto undefined antigen present on virtually all normal lymphocytes and monocytes. Its reactivity with 105 samples of fresh leukaemic cells and 13 cell lines was measured by indirect fluorescence and peroxidase staining to define in more detail w...

Full description

Bibliographic Details
Main Authors:	Hale, G, Swirsky, D, Waldmann, H, Chan, L
Format:	Journal article
Language:	English
Published:	1985

Similar Items

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
by: Waldmann, H, et al.
Published: (1985)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
by: Waldmann, H, et al.
Published: (1985)

Availability of Campath-1 antibodies for bone marrow transplantation.
by: Hale, G, et al.
Published: (1995)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
by: Waldmann, H, et al.
Published: (1987)

Specificity of monoclonal antibody Campath-1.
by: Hale, G, et al.
Published: (1988)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
by: Naparstek, E, et al.
Published: (1993)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
by: Naparstek, E, et al.
Published: (1999)

Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
by: Morgan, G, et al.
Published: (1986)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
by: Dyer, M, et al.
Published: (1988)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
by: Rebello, P, et al.
Published: (1999)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
by: Fibbe, W, et al.
Published: (1993)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
by: Hale, G, et al.
Published: (1986)

HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION - INVIVO CONDITIONING WITH MONOCLONAL-ANTIBODIES
by: Fasth, A, et al.
Published: (1988)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
by: Lim, S, et al.
Published: (1993)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
by: Isaacs, J, et al.
Published: (1996)

Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.
by: Singhal, S, et al.
Published: (1996)

CAMPATH-1 antibodies in stem-cell transplantation.
by: Hale, G, et al.
Published: (2001)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
by: Dyer, M, et al.
Published: (1990)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
by: Apperley, J, et al.
Published: (1985)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
by: Friend, P, et al.
Published: (1991)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
by: Hale, G, et al.
Published: (1989)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
by: Isaacs, J, et al.
Published: (1995)

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
by: Apperley, J, et al.
Published: (1986)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
by: Hale, G, et al.
Published: (1998)

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
by: Naparstek, E, et al.
Published: (1995)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
by: Waldmann, H, et al.
Published: (1982)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
by: Williams, R, et al.
Published: (2000)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
by: Newman, D, et al.
Published: (1995)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
by: Hale, G, et al.
Published: (1988)

In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
by: Willemze, R, et al.
Published: (1992)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
by: Hale, G, et al.
Published: (1983)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
by: Novitzky, N, et al.
Published: (1997)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
by: Novitzky, N, et al.
Published: (1997)

RAT MONOCLONAL-ANTIBODIES TO PREVENT G-VS-H AND H-VS-G REACTIONS IN BONE-MARROW TRANSPLANTATION
by: Waldmann, H, et al.
Published: (1986)

Monoclonals and marrow transplants.
by: Waldmann, H, et al.
Published: (1986)

CAMPATH: from concept to clinic.
by: Waldmann, H, et al.
Published: (2005)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
by: Hale, G, et al.
Published: (1996)